These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38480977)
1. Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT. Kuo YY; Huo C; Li CY; Chuu CP Cancer Gene Ther; 2024 Jun; 31(6):807-815. PubMed ID: 38480977 [TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213. Kuo YY; Huo C; Lin CY; Lin HP; Liu JS; Wang WC; Chang CR; Chuu CP Cell Commun Signal; 2019 Aug; 17(1):100. PubMed ID: 31429764 [TBL] [Abstract][Full Text] [Related]
3. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells. Tseng JC; Wang BJ; Wang YP; Kuo YY; Chen JK; Hour TC; Kuo LK; Hsiao PJ; Yeh CC; Kao CL; Shih LJ; Chuu CP Phytomedicine; 2023 Jul; 116():154860. PubMed ID: 37201366 [TBL] [Abstract][Full Text] [Related]
4. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Chuu CP; Lin HP; Ciaccio MF; Kokontis JM; Hause RJ; Hiipakka RA; Liao S; Jones RB Cancer Prev Res (Phila); 2012 May; 5(5):788-97. PubMed ID: 22562408 [TBL] [Abstract][Full Text] [Related]
5. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Tseng JC; Lin CY; Su LC; Fu HH; Yang SD; Chuu CP Oncotarget; 2016 Jun; 7(25):38010-38024. PubMed ID: 27191743 [TBL] [Abstract][Full Text] [Related]
6. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262 [TBL] [Abstract][Full Text] [Related]
7. Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells. Sarwar M; Semenas J; Miftakhova R; Simoulis A; Robinson B; Gjörloff Wingren A; Mongan NP; Heery DM; Johnsson H; Abrahamsson PA; Dizeyi N; Luo J; Persson JL Oncotarget; 2016 Sep; 7(39):63065-63081. PubMed ID: 27588408 [TBL] [Abstract][Full Text] [Related]
8. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells. Liu L; Dong X PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799 [TBL] [Abstract][Full Text] [Related]
9. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference. Fu YK; Wang BJ; Tseng JC; Huang SH; Lin CY; Kuo YY; Hour TC; Chuu CP J Biomed Sci; 2022 Feb; 29(1):16. PubMed ID: 35197069 [TBL] [Abstract][Full Text] [Related]
10. Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancer. Wang J; Liu H; Yu Z; Zhou Q; Sun F; Han J; Gao L; Dou B; Zhang H; Fu J; Jia W; Chen W; Hu J; Han B Cell Commun Signal; 2024 Jun; 22(1):339. PubMed ID: 38898473 [TBL] [Abstract][Full Text] [Related]
11. Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy. Liu VWS; Yau WL; Tam CW; Yao KM; Shiu SYW Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561752 [TBL] [Abstract][Full Text] [Related]
12. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth. Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814 [TBL] [Abstract][Full Text] [Related]
14. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells. Lin HP; Jiang SS; Chuu CP PLoS One; 2012; 7(2):e31286. PubMed ID: 22347457 [TBL] [Abstract][Full Text] [Related]
15. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells. Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the androgen receptor splicing in prostate cancer cells. Liu LL; Xie N; Sun S; Plymate S; Mostaghel E; Dong X Oncogene; 2014 Jun; 33(24):3140-50. PubMed ID: 23851510 [TBL] [Abstract][Full Text] [Related]
17. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer. Liu CC; Hsu JM; Kuo LK; Chuu CP Med Hypotheses; 2013 May; 80(5):617-9. PubMed ID: 23462369 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells. Krause WC; Shafi AA; Nakka M; Weigel NL Int J Biochem Cell Biol; 2014 Sep; 54():49-59. PubMed ID: 25008967 [TBL] [Abstract][Full Text] [Related]
20. AR-v7 protein expression is regulated by protein kinase and phosphatase. Li Y; Xie N; Gleave ME; Rennie PS; Dong X Oncotarget; 2015 Oct; 6(32):33743-54. PubMed ID: 26378044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]